New study reveals potential cognitive benefits of Shingrix vaccine. The shingles shot may offer protection against dementia, ...
Martin has since learned that shingles is caused by the reactivation of the varicella zoster virus, the same virus that ...
Getting the Shingrix vaccine after the age of 50 can reduce your chances of developing the painful skin condition known as ...
While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...
Shingrix grew 19% to £833 million in the quarter, backed up by solid performances for meningitis vaccines Bexsero and Menveo, which rose 34% to £218 million and 40% to £59 million, respectively.
The First in China! BLA Submitted for Luzhu Biotech's Recombinant Herpes Zoster Vaccine Expected to Be Launched in 2026 HONG KONG ...
India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand ...
Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) reflecting updated views and recent competitive dynamics for vaccines. Goldman Sachs analyst Paul Choi has downgraded Dynavax to ...
More than 90,000 people in the Netherlands contract shingles each year, a painful viral infection that can lead to lifelong ...
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...
Dynavax Technologies Corp (DVAX) reports record revenue for Heplisav-B, advances in vaccine programs, and strategic financial positioning despite rising R&D costs.
In the vaccines segment, GSK maintained its leadership in the self-pay private market for Paediatric vaccines, the company ...